Detailed answers about BIOGEN X PHARMACEUTICAL LTD, including incorporation, status, business activity, and accounts information.
When was BIOGEN X PHARMACEUTICAL LTD founded?
BIOGEN X PHARMACEUTICAL LTD was officially incorporated on 28 May 2025 and is registered under company number 16479910. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BIOGEN X PHARMACEUTICAL LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of BIOGEN X PHARMACEUTICAL LTD?
BIOGEN X PHARMACEUTICAL LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BIOGEN X PHARMACEUTICAL LTD do?
BIOGEN X PHARMACEUTICAL LTD operates in the following sectors: 21100 - Manufacture of basic pharmaceutical products, 21200 - Manufacture of pharmaceutical preparations, 32500 - Manufacture of medical and dental instruments and supplies, 46460 - Wholesale of pharmaceutical goods. These SIC codes provide insight into the company's business activities and industry focus.
What is BIOGEN X PHARMACEUTICAL LTD's registered address?
The registered office address of BIOGEN X PHARMACEUTICAL LTD is 167-169 GREAT PORTLAND STREET, 5TH FLOOR,, LONDON, ENGLAND, W1W 5PF. This is the official address filed with Companies House for legal and statutory correspondence.
Is BIOGEN X PHARMACEUTICAL LTD financially stable?
Financial accounts for BIOGEN X PHARMACEUTICAL LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.